Intrinsiqq
Embecta Corp. logo

Embecta Corp. Financials

EMBC

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 7 available years
Income Statement
TTM
SEP 2025
SEP 2024
SEP 2023
SEP 2022
SEP 2021
Revenues
Revenue$1,019$1,080$1,123$1,121$1,130$1,165
Cost of Revenue$417$404$388$371$355$365
Gross Profit$601$677$735$750$775$800
General & Administrative$319$332$365$341$295$240
Research & Development$20$37$79$85$67$63
Other Operating Expenses$26-$1$0-$1––
Total Operating Expenses$378$435$568$528$465$308
Operating Income$235$242$291$222$310$492
Other Non-Operating Income (Expense)-$2$2-$10-$9-$7$3
EBT (Earnings Before Tax)$125$136$44$106$257$495
Income Tax Expense$38$41-$34$35$33$80
Net Income
Net Income$88$95$78$70$224$415
Per Share Data
Revenue Per Share$17.41$18.34$19.26$19.41$19.66$20.44
EPS (Basic)$1.50$1.64$1.36$1.23$3.92$7.28
EPS (Diluted)$1.47$1.62$1.34$1.22$3.89$7.28
Weighted Avg Shares (Basic)58.5M58.3M57.7M57.2M57.0M57.0M
Weighted Avg Shares (Diluted)58.5M58.9M58.3M57.8M57.5M57.0M
Shares Outstanding58.5M58.9M58.3M57.8M57.5M57.0M
Dividends Per Share$0.46$0.60$0.60$0.60$0.15$0.00

Embecta (EMBC) financials: revenue, profit and margins

Embecta (EMBC) generated about $1.0 billion in revenue and $88 million in net income (a 8.6% net margin) over the trailing twelve months, growing at roughly -0.1% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Embecta's (EMBC) revenue?+

Embecta generated about $1.0 billion in revenue over the trailing twelve months. Revenue has grown at roughly -0.1% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Embecta profitable?+

Yes, Embecta reported about $88 million in net income over the trailing twelve months, a net profit margin of roughly 8.6%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Embecta's profit margins?+

Embecta runs a gross margin of about 59.0%, an operating margin of about 23.0%, a net margin of about 8.6%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Embecta growing?+

Embecta's revenue has compounded at roughly -0.1% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside EMBC's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 31 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 18 Sept 2026. How this is calculated.

Fiscal year ends Sep.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with EMBC

CompareIntrinsic value
TNDMTandem Diabetes Care Inc.
$19.05+7.93%26
INSPInspire Medical Systems, Inc.
$66.61+7.61%81
OFIXOrthofix Medical Inc.
$9.72+10.96%18
IRTCIrhythm Technologies Inc.
$134.00+6.04%45
ATECAlphatec Holdings Inc.
$8.28+10.84%45
NVCRNovoCure Ltd.
$14.61+8.79%24
HAEHaemonetics Corporation
$127.42+5.94%53
UFPTUFP Technologies Inc.
$329.82+17.66%40

Held by ETFs

EMBC is in 30 US ETFs. The largest of them, with EMBC's weight in each:

Spot a number that looks wrong? Check it in EMBC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EMBC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.